<DOC>
	<DOCNO>NCT03022968</DOCNO>
	<brief_summary>Recently revise Alzheimer Disease ( AD ) diagnostic1described nonamnestic presentation : 1/ language presentation ( logopenic progressive aphasia ) 2/ visuospatial presentation ( posterior cortical atrophy PCA ) 3/ executive dysfunction . AD pathological change may precede clinical diagnosis dementia AD type while2 . Biomarkers develop : biomarkers brain amyloid-beta ( Aß ) ( CerebroSpinal Fluid CSF concentration ßamyloid , molecular image amyloid target PET ligand ) , biomarkers neural degeneration ( MRI hippocampal volume , regional metabolism assess PET [ 18F ] -FDG ) may use make early detection neuropathology associate AD Even CSF biomarkers ( tau , p-tau β amyloïd interest improve diagnosis AD , provide topographic information . PET tau image seem promise evaluate quantitative spatial assessment tau lesion AD fronto-temporal lobar dementia . The hypothesis research exist different regional pattern tracer retention across brain region accord clinical symptom : temporal logopenic aphasia occipital posterior cortical atrophy .</brief_summary>
	<brief_title>Tau Brain Imaging Typical Atypical Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>50 year old native langage : french study level upper ( equal ) 7 year ( consider first year grammarschool start ) correct sensory ability ( auditive device allow ) test affiliation social security Informed , write consent form Alzheimer disease group : people Alzheimer Disease define National Institute Neurological Communicative Disorders Stroke ( NINCDS ) Alzheimer 's Disease Related Disorders Association ( ADRDA ) standard : Light mild AD define MiniMental State Examination ( MMSE ) score 15 25 ( include ) Benson disease group : Benson disease follow Mendez et al ( 2002 ) Tang Wai et al ( 2004 ) criterion healthy volunteer group : normal MMS score ( 26 bachelor level ) history disease consequances cognitive functioning ( tumor , stroke , head trauma , etc . ) , cerebral surgery use alchohol and/or drug anormalies neurological exam ( focal deficit ) include classic symptom contraindication magnetic resonance imaging ( RMI ) contraindication PET : people prolongation QT interval take medication lead `` torsades de pointe '' . claustrophobia person legal protection exclusion period participation another experimental protocol actual participation experimental protocol pregnant lactate woman able procreate without contraception</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>